Infection control solutions are the measures and technologies that prevent and reduce the spread of pathogens in a healthcare setting, across water, air and surfaces. The strongest go beyond easy targets to the biofilm and antimicrobial-resistant organisms conventional disinfection leaves behind, and prove every result to an independent or accredited laboratory.
Hospitals are being asked to hold the line on infection with disinfection that resistant, biofilm-forming pathogens increasingly survive, while every failure carries clinical, financial and regulatory cost.
Healthcare-associated infection already costs the NHS between roughly GBP 774m and GBP 2.1bn a year, adds about GBP 1,457 to the cost of every case, and ties up close to a fifth of bed capacity. Each outbreak is also a reputational and regulatory event.
Antimicrobial resistance is making it worse. More than 1.2 million people already die from resistant infections each year, a figure projected to reach 10 million by 2050, and the pathogens that matter most form biofilms that are around a thousand times more resistant to conventional disinfectants than free-floating cells.
At the same time, statutory water and ventilation standards (HTM 04-01 for Legionella and water safety, HTM 03-01 for ventilation) carry direct CQC enforcement, and the national AMR action plan now holds you to preventing any rise in gram-negative bloodstream infections. The duty is continuous, and the evidence has to be there on inspection.
We target the exact failure mode conventional control struggles with, biofilm and resistant pathogens in your water and air, and leave you with the verified evidence your duties require.
Across water systems, surfaces and indoor air, we deploy disinfection and purification that work against antimicrobial-resistant and biofilm-forming organisms, not just the easy targets. The result is lower bioburden where infection actually starts, with no ozone or harmful byproducts and no toxic residue left in a clinical environment.
It fits the estate and the care you already run. There is no need to take wards, theatres or water systems out of service, and every outcome is independently verified, so the same work that lowers infection risk also produces the HTM and CQC evidence your Water Safety Group and inspectors expect. One accountable partner carries the integration.
Bring waterborne bioload down and keep it down. A recurring pathogen problem was eliminated to 0 cfu/g in four days where conventional dosing had failed for years, confirmed by a UKAS-accredited laboratory.
Target the biofilm where antimicrobial-resistant organisms hide and survive, with independently verified removal of 99.99% of biofilm (ASTM E2799), the exact failure mode conventional disinfection struggles with.
Remove 99.9% of airborne pathogens, including H1N1 influenza and COVID-19, in SGS-certified independent testing, with no ozone or harmful byproducts, in wards, theatres, immunocompromised rooms and surgical areas where air quality is a clinical outcome.
Meet HTM 04-01 and HTM 03-01 duties and the national AMR action plan with independently verified results your Water Safety Group and CQC inspectors can rely on.
For new-build and international facilities, a proven pathway to JCI accreditation, with environmental and infection-control standards designed in from the start.
Reduce energy and water running cost across a continuously operating estate, and take out the recurring cost of repeat treatment, outbreaks and lost bed-days.
Clinically relevant evidence, independently verified.
The UK environmental and safety duties that commonly reach infection control solutions. Open any one for what it requires, the deadlines, what is at stake, and how to evidence control. Every entry is sourced.
The first question any infection-control or estates team asks is the right one: show me the clinical evidence, and tell me it will not disrupt care.
So we lead with both. Every outcome is backed by independent, accredited or peer-reviewed evidence, framed for your Water Safety Group and your CQC file. It works around live clinical operations, with no need to take wards, theatres or water systems offline, and it keeps you within HTM 04-01 and HTM 03-01. We start with an infection-risk review of one system or area, prove the result, then extend it across the estate.
They are the measures and technologies that prevent and reduce the spread of pathogens in a healthcare setting, across water, air and surfaces. The strongest go beyond easy targets to the biofilm and antimicrobial-resistant organisms conventional disinfection leaves behind, and prove every result to an independent or accredited laboratory.
By lowering bioburden where infection actually starts, in water, air and on surfaces, rather than reacting after an outbreak. It matters because healthcare-associated infection costs the NHS between roughly GBP 774m and GBP 2.1bn a year, adds about GBP 1,457 to every case and ties up close to a fifth of bed capacity.
Biofilm is the protective layer micro-organisms form on wet surfaces, in pipework and on equipment. It matters because the pathogens inside it are around a thousand times more resistant to conventional disinfectants than free-floating cells, which is why infection rebounds between chemical shocks. Independent testing confirms removal of 99.99% of biofilm (ASTM E2799).
By bringing waterborne bioload down at source and holding it down, with independently verified results for your Water Safety Group. A recurring pathogen problem was eliminated to 0 cfu/g in four days where conventional dosing had failed for years, with Legionella, E. coli and coliforms eliminated, confirmed by a UKAS-accredited laboratory.
Yes. It targets exactly those organisms. Resistant pathogens survive in biofilm that is around a thousand times more resistant to conventional disinfectants, and independent and peer-reviewed testing confirms activity against resistant strains and removal of 99.99% of biofilm.
No. The approach is designed to work around live clinical care. There is no need to take wards, theatres or water systems out of service while infection risk is reduced, so the estate and the care you already run stay in operation.
Yes. Results are confirmed by UKAS-accredited and water-authority laboratories and supported by SGS-certified and peer-reviewed testing, including elimination of waterborne pathogens to 0 cfu/g, removal of 99.99% of biofilm (ASTM E2799) and removal of 99.9% of airborne pathogens including H1N1 influenza and COVID-19.
Tell us where infection or compliance risk sits hardest in your estate. We will review it and show you the outcome, in confidence, before you commit.
Tell us the cost, the risk or the obligation you are facing. A senior member of our team will respond, in confidence, with how we would help.
